Status:
COMPLETED
Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone
Lead Sponsor:
ACTEON Group
Collaborating Sponsors:
Slb Pharma
Conditions:
Root Canal Obturation
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study aims to assess the efficacy of a zinc oxide eugenol sealer containing Enoxolone, a non-steroidal anti inflammatory drug (NSAID) on the pain relief after endodontic treatment. The study des...
Eligibility Criteria
Inclusion
- male or female aged from 18 to 70 years,
- patient requiring root canal treatment on permanent mature teeth (single rooted teeth, premolar or molar),
- Informed consent signed,
- Patient with social protection.
Exclusion
- root canal retreatment,
- root canal treatment on an immature tooth,
- calcified root canal assessed radiographically,
- Patient with one or more documented contraindication to endodontic treatment,
- Patient who takes regular analgesic or anti-inflammatory therapy for another pathology,
- Known allergy to NSAID or to one component of the sealer formula,
- Participation to another clinical trial at the same time,
- known pregnancy or lactation,
- Patients with legal protection.
Key Trial Info
Start Date :
April 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2019
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT03874949
Start Date
April 2 2019
End Date
August 20 2019
Last Update
September 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet dentaire
Rennes, France, 35000